Born out of a desire to improve health outcomes and solve the global healthcare crises with their patient monitoring device, Dozee, a healthtech startup, joins the American market to serve everyone – starting with the Indian American community.
Made in India, Dozee’s Shravan is a contactless remote patient monitoring system and AI-based early warning system for critical care. Various health parameters like heart rate, blood pressure, respiration, and more are recorded “without even touching the user” and through AI, the data is analyzed to find alarming health patterns. The users are then notified of their ailments and early-stage corrective measures are pursued.
The health monitoring device, which is U.S. FDA-cleared and HIPAA-compliant, has already proven itself in the Indian market by being integrated in more than 380 hospitals in 50 districts around the country. Dozee boasts more than 16,000 life-saving alerts.
The device was launched in Bangalore on October 8.
Shravan will be marketed in the United States by Tampa-based MediGlobo, founded by Indian American entrepreneur Sid Panigrahy.
“MediGlobo is glad to partner with Dozee Shravan for the U.S. market,” Panigrahy told The American Bazaar. “I have personally experienced the concerns for the family’s well-being back home, and also observed the same concerns in my fellow NRIs. Dozee Shravan goes a long way in catering to this concern. Dozee Shravan’s promise of constant monitoring of vital biomarkers and the ease in which this data is available on mobile phones, makes this device a standout product that promises to be popular with the diaspora.”
Panigrahy said MediGlobo initially plans launch Shravan in New Jersey “shortly,” and gradually expand it to other states” with heavy Indian American concentration. “I have no doubt that Dozee Shravan will be popular with the over 4 million strong Indian diaspora in the U.S.,” the Tampa businessman said.
READ: Ex-Microsoft leads raise $11 million for their AI-powered B2B startup (October 3, 2024)
Founded in 2015 by IIT graduates, Mudit Dandwate and Gaurav Parchani, the healthtech startup raised $6 million in a Series A funding round earlier this year from new and existing investors.
From race car engineer to healthcare entrepreneur, Dandwate, who is the CEO and co-founder of Dozee, spoke to The American Bazaar about its launch in the North American market.
“It can save lives,” Dandwate said, talking about the transformational impact that Dozee can have when implemented at a large scale. Having emerged as a clear leader in the Indian healthcare landscape, the evident next step is going global, Dandwate noted.
Planning to launch their AI-powered technology in geographies such as New Jersey, Texas, Chicago, Florida, and California, the Non-Resident Indian (NRI) community is their go-to market for now.
“For millions of NRIs, distance from aging parents in India poses critical health management challenges,” a statement from Dozee said, suggesting that their real-time monitoring solution empowers families to take care of their loved ones from afar while adhering to international data security and privacy.
“Shravan embodies the essence of parental care in Indian culture,” Dandwate said.
Along with enhancing patient safety and care, minimizing nursing hours and improving patient overall medical experience are the fundamental pillars that Dozee operates on, Dandwate added.
READ: AI software startup Poolside secures $500 million Series B funding (October 2, 2024)
Fellow founder and CTO, Gaurav Parchani, is a mechanical engineer from IIT Indore. Alongside Dandwate, he worked for Altair Technologies as a vehicle dynamics expert before coming together to build Dozee.
Sameer Dashputre joined Dozee as the Chief Strategy Officer in 2019, according to his Linkedin. In discussing India’s Union Budget 2024, Dashputre told the Financial Express that AI technologies can bridge gaps in providing quality healthcare services which aligns with Dozee’s ethos.